Learn Laws

Call Directions Website Contact the business

Learn Laws Learn Laws® provides daily legal videos. Hit that follow button.

Drug Testing Courses offers the most comprehensive and accredited DOT and non-DOT drug testing, DNA and paternity testing education and development courses

10/16/2026

The Federal Motor Carrier Safety Administration (FMCSA) is warning about fake emails and websites that pretend to be Motus, its website application. Per FMCSA's Fraud Alerts page, under "Bogus Motus App and Links," updated Thursday, October 15, 2026, the emails claim a required off cycle profile update and point to a "New MOTUS Portal."

FMCSA says the only legitimate Motus site is on the dot.gov domain, and it lists five fake portal addresses that end in .com. It also says its own messages come from its website, its Customer Service Center, or email addresses with .gov. This is a fraud alert, not a rule. FMCSA advises hovering over any link to see the real address before clicking, and reporting scams to the Federal Trade Commission.

If you are the target of one of these emails, FMCSA says to call the FMCSA Contact Center at 1-800-832-5660.

10/15/2026

Per Food and Drug Administration (FDA) Federal Register final order 2026-20448, "Certain Clinical Toxicology Test Systems," published Tuesday, October 6, 2026, certain drug test systems meant for Federal drug testing programs no longer need FDA premarket clearance, known as a 510(k). This is a final order, not a proposal. It took effect Tuesday, October 6, 2026, under Docket FDA-2026-N-4268.

The exemption already covered these tests when intended for employment and insurance testing, except when meant for Federal programs. FDA removed that exception for 14 test types, including amphetamine, co***ne, op**te, and cannabinoid tests. Makers still must meet registration, listing, labeling, and quality management system rules. When the tests are used in Federal programs, the mandatory guidelines of the Substance Abuse and Mental Health Services Administration (SAMHSA) still apply. FDA says tests it already authorized can still be used, and that it does not decide whether oral fluid or hair testing may be used in Federal programs.

For questions, the notice names Joseph Kotarek, FDA Center for Devices and Radiological Health, 301-796-2718.

10/15/2026

Per FMCSA's Federal Register notice 2026-17893, "Fees for the Unified Carrier Registration Plan and Agreement," published Tuesday, September 1, 2026, annual Unified Carrier Registration (UCR) fees go up for the 2027 registration year and later years. FMCSA is the Federal Motor Carrier Safety Administration. This is a final rule, effective Thursday, October 1, 2026, under Docket FMCSA-2025-0655.

The increase averages 20 percent over the fees used for 2025 and 2026. It applies to motor carriers, motor private carriers of property, brokers, freight forwarders, and leasing companies. Fees depend on the number of commercial motor vehicles owned or operated. Zero to two vehicles, and all brokers and leasing companies, now pay $55, up from $46. Three to five vehicles pay $167. Six to 20 pay $333. 21 to 100 pay $1,163. 101 to 1,000 pay $5,548. 1,001 and above pay $54,165. FMCSA says collections for a fee year begin October 1 of the year before, and the 2027 schedule stays in place until a future rulemaking changes it.

For questions, the notice names Kenneth Riddle, Director, Office of Registration, FMCSA, 1200 New Jersey Avenue SE, Washington, DC 20590.

10/15/2026

The Occupational Safety and Health Administration (OSHA) released a fact sheet on Thursday, September 24, 2026, titled "Opioid Overdose Rescue with Reversal Medications" (DSG FS-4519, announced in OSHA news release 26-1550-NAT). It tells managers, supervisors, and employees what to do if someone overdoses at work.

This is guidance, not a new rule or standard. OSHA states the fact sheet does not impose any new compliance requirements. It suggests keeping naloxone or nalmefene, the two overdose reversal medications approved by the Food and Drug Administration, in visible, easy to reach spots such as next to first aid kits and defibrillators. It says to assign someone, such as a safety officer, to track expiration dates and restock. It also suggests a voluntary training program on the signs of an overdose, including slow or stopped breathing, blue lips, unresponsiveness, and pinpoint pupils, and on how to give the medication and place someone in the recovery position. Workers should call 911 every time, because the medication's effects are temporary and more than one dose may be needed.

For questions, the fact sheet directs employers and workers to their regional or area OSHA office or 1-800-321-OSHA (6742).

10/15/2026

The Drug Enforcement Administration (DEA) plans to temporarily place 7-hydroxymitragynine, a kratom alkaloid, and mitragynine pseudoindoxyl in schedule I of the Controlled Substances Act when a product contains them above a set threshold. Per DEA's Federal Register notice 2026-20943 (Docket No. DEA-1570), published Wednesday, October 14, 2026, this is a notice of intent, not a final order. DEA is withdrawing its July 2026 notice, which used a lower threshold.

The threshold is more than 1 milligram per gram in solid products, more than 1 milligram per milliliter in liquids, or less than 100 times as much mitragynine as these substances. The temporary order will be published on or after Friday, November 13, 2026. Once it is, schedule I controls and administrative, civil, and criminal sanctions will apply to anyone who makes, distributes, or possesses these substances above the threshold. Products below the threshold could stay on the market, but the notice states that neither DEA nor the Department of Health and Human Services has found them safe to use.

The notice names DEA's Drug and Chemical Evaluation Section, Diversion Control Division, at (571) 362-3249 for further information.

10/15/2026

WorkTraining.com is now LearnLaws.com

Starting today, October 15, 2026, WorkTraining.com is LearnLaws.com. You don't need to do anything. Your login, courses and certificates all carry over.

Same ownership, same management, same team. This is a name change, not a sale or merger. Since 2014 we've grown from a drug and alcohol testing catalog to training on sexual harassment, HIPAA, bloodborne and airborne pathogens, driver safety and more, with new programs every month.

Every course is Attorney Trusted®, which means an attorney reviews it before it's released. Thank you to the thousands of employers and learners who have trained with us. Questions? Call 1-888-390-5574, Monday through Friday, 9 AM to 5 PM ET.

10/15/2026

The Environmental Protection Agency (EPA) published a final rule on Tuesday, October 13, 2026, delaying the compliance date for Clean Water Act Hazardous Substance Facility Response Plans, per Federal Register notice 2026-20849 (91 FR 64774), Docket EPA-HQ-OLEM-2021-0585.

Covered onshore facilities that are not transportation related and that could reasonably be expected to cause substantial harm from a worst case discharge of a Clean Water Act hazardous substance now must prepare and submit those Facility Response Plans by Saturday, June 1, 2030, instead of Monday, June 1, 2027. The final rule takes effect on Monday, December 14, 2026. EPA states the delay gives the Agency time to consider compliance assistance tools and whether further revisions are needed. The rule also removes climate change and environmental justice references from the part 118 Facility Response Plan requirements.

For questions, contact Melissa Kaps, Waste and Chemicals Implementation Division, Office of Resource Conservation and Recovery, EPA, at (202) 566-0501 or [email protected].

10/15/2026

The Environmental Protection Agency (EPA) proposed a rule on Wednesday, October 14, 2026, to push back certain trichloroethylene (TCE) ban deadlines under the Toxic Substances Control Act (TSCA). Per Federal Register notice 2026-20964, published Wednesday, October 14, 2026 (91 FR 65148), titled Trichloroethylene (TCE) Regulation Under the Toxic Substances Control Act (TSCA) Compliance Date Extensions, this is a proposal, not a final rule.

EPA would move prohibition dates for processing TCE as a reactant or intermediate, industrial and commercial use of TCE as a processing aid (including uses in battery manufacture, polymer fiber spinning, fluoroelastomer and Alcantara manufacture, and related solvent or precipitant uses), and related wastewater disposal from December 18, 2026, to December 31, 2027. It would also move one HFC-134a refrigerant feedstock phaseout step, the 75 percent of baseline volume limit, from June 7, 2027, to December 31, 2027. Downstream safety data sheet and notification text would have to match the new dates within 30 days after a final rule publishes.

Comments are due by Friday, November 13, 2026, through the Federal eRulemaking Portal under docket EPA-HQ-OPPT-2026-7327. The notice names Simon Regenold, Existing Chemicals Risk Management Division, at (202) 566-1537 for technical information.

10/14/2026

The Substance Abuse and Mental Health Services Administration (SAMHSA), part of the Department of Health and Human Services (HHS), published its monthly list of drug testing laboratories certified under the Mandatory Guidelines for Federal Workplace Drug Testing Programs. Per Federal Register notice 2026-20004, published Wednesday, September 30, 2026 (91 FR 61854), this is a notice, not a rule, and it changes no testing requirements.

The list shows no laboratory currently certified to test oral fluid specimens. Fourteen laboratories are certified for urine testing, two of them for Veterans Affairs or Defense Department employees only. One Instrumented Initial Testing Facility is listed, Dynacare in Edmonton, Alberta, and the notice states that the Department of Transportation does not allow these facilities to test its regulated specimens.

A laboratory whose certification is suspended or revoked is left off later lists until it is restored, and laboratories still in the applicant stage do not meet the minimum standards. The notice names Anastasia Flanagan, Division of Workplace Programs, SAMHSA, at (240) 276-2600 for further information.

10/14/2026

U.S. Citizenship and Immigration Services (USCIS) proposed a rule on Wednesday, October 14, 2026 that would end deference to earlier approvals when employers ask to extend a worker petition. Per Federal Register notice 2026-20941, "Removing Deference to Prior USCIS Determinations of Eligibility," it would remove the deference provision at 8 CFR 214.1(c)(5). This is a proposal, not a final rule.

Today, officers generally defer to a prior approval on Form I-129 (the petition for a nonimmigrant worker) when the parties and facts are the same, unless there was a material error, a material change, or new material information. Under the proposal, each extension request would be reviewed on its own merits. The Department of Homeland Security (DHS) estimates about 6,044 more requests for evidence a year and identified 22,748 affected employers.

Comments are due by Friday, November 13, 2026, through the Federal eRulemaking Portal under DHS Docket No. USCIS-2026-0529. The notice says mailed, emailed, and hand delivered comments will not be accepted.

Address

508 N Harbor City Boulevard
Melbourne, FL
32935

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 7pm
Thursday 9am - 7pm
Friday 9am - 5pm

Telephone

+1 888-390-5574

Website

,

Alerts

Be the first to know and let us send you an email when Learn Laws posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Learn Laws:

Shortcuts

Share

Category